Ergoteles’s Genprex GNPX Stock Holding History

Ergoteles’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2	Closed	-$200K	–	1374
2021 Q3	$200K	Sell	2 -1	-33%	-$129K	0.01%	1006
2021 Q2	$446K	Buy	+3	New	+$492K	0.01%	865

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Ergoteles's GNPX Position: Q4 2021 in Review

Ergoteles sold out of Genprex (GNPX) in Q4 2021, closing a stake of 2 shares — an estimated $200K sold.

Ergoteles first reported a position in GNPX in Q2 2021 and held it in 2 quarters. The position peaked at $446K in Q2 2021. 25 funds tracked by Wall St. Rank hold GNPX as of Q4 2021.

Ergoteles reported no remaining Genprex position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 2 Genprex shares in Q4 2021, an estimated $200K.
Ergoteles first reported a position in Genprex in Q2 2021 and held it in 2 quarters.
Ergoteles's Genprex position peaked at $446K in Q2 2021.
25 funds tracked by Wall St. Rank held Genprex as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.